- Report
- July 2019
- 29 Pages
Global
From €3850EUR$3,995USD£3,311GBP
- Training
- July 2022
- 1 Hour
Global
- Training
- 2 Hours
Global
- Report
- October 2019
- 742 Pages
Global
From €6793EUR$7,050USD£5,844GBP
- Report
- January 2022
- 141 Pages
France
From €5943EUR$6,168USD£5,112GBP
- Report
- September 2023
- 140 Pages
Global
From €2890EUR$2,999USD£2,486GBP
- Report
- September 2023
- 160 Pages
Global
From €2890EUR$2,999USD£2,486GBP
- Report
- September 2023
- 140 Pages
Global
From €2890EUR$2,999USD£2,486GBP
- Report
- May 2023
- 140 Pages
Global
From €5781EUR$5,999USD£4,972GBP
- Book
- November 2023
- 560 Pages
- Book
- July 2021
- 816 Pages
- Book
- November 2018
- 1088 Pages
The Human Reproduction market within the context of Women's Health is a broad field of research and development that focuses on the reproductive health of women. It includes the study of fertility, contraception, pregnancy, childbirth, and postpartum care. It also covers the diagnosis and treatment of reproductive disorders, such as infertility, endometriosis, and polycystic ovary syndrome. Additionally, it encompasses the study of reproductive technologies, such as in vitro fertilization, and the use of assisted reproductive technologies.
The Human Reproduction market is an important part of Women's Health, as it helps to ensure that women have access to the best possible care and treatments for their reproductive health. It also helps to ensure that women have access to the latest technologies and treatments for their reproductive health.
Some companies in the Human Reproduction market include Bayer AG, Merck & Co., Inc., Pfizer Inc., and Sanofi. Show Less Read more